Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis
暂无分享,去创建一个
I. Shih | Tian-Li Wang | R. Kurman | A. Meeker | E. Kuhn | A. S. Sehdev
[1] Ie-Ming Shih,et al. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.
[2] I. Shih,et al. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase , 2010, Modern Pathology.
[3] J. Lubiński,et al. Elevated level of 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls , 2009, International journal of cancer.
[4] P. Lansdorp. Telomeres and disease , 2009, The EMBO journal.
[5] P. Shaw,et al. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers , 2009, Modern Pathology.
[6] I. Shih,et al. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. , 2009, Cancer research.
[7] G. Roos,et al. Telomere length as a biological marker in malignancy. , 2009, Biochimica et biophysica acta.
[8] N. Zaffaroni,et al. Targeting the telosome: therapeutic implications. , 2009, Biochimica et biophysica acta.
[9] Allan G. Rempel,et al. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. , 2008, Gynecologic oncology.
[10] Kwok-Kin Wong,et al. Differential roles of telomere attrition in type I and II endometrial carcinogenesis. , 2008, The American journal of pathology.
[11] B. Rosen,et al. Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from BRCA Mutation Carriers Resemble High-Grade Serous Carcinoma , 2008, Clinical Cancer Research.
[12] J. Garber,et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube (J Pathol 2007; 211: 26–35) , 2007, The Journal of pathology.
[13] I. Shih,et al. Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance , 2007, International Journal of Gynecologic Cancer.
[14] D. Feldser,et al. Short telomeres limit tumor progression in vivo by inducing senescence. , 2007, Cancer cell.
[15] A. Multani,et al. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53‐dependent cellular senescence , 2007, EMBO reports.
[16] R. Berkowitz,et al. Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.
[17] A. Meeker,et al. Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung. , 2007, American journal of clinical pathology.
[18] R. Drapkin,et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis , 2007, Current opinion in obstetrics & gynecology.
[19] K. Lillemoe,et al. Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma , 2006, Modern Pathology.
[20] M. Muto,et al. Advances in the Recognition of Tubal Intraepithelial Carcinoma: Applications to Cancer Screening and the Pathogenesis of Ovarian Cancer , 2006, Advances in anatomic pathology.
[21] R. DePinho,et al. Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.
[22] R. Reddel,et al. The first molecular details of ALT in human tumor cells. , 2005, Human molecular genetics.
[23] Gordon B Mills,et al. Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon , 2005, Clinical Cancer Research.
[24] J. Shay,et al. Senescence and immortalization: role of telomeres and telomerase. , 2005, Carcinogenesis.
[25] S. Jackson,et al. Human cell senescence as a DNA damage response , 2005, Mechanisms of Ageing and Development.
[26] P. Argani,et al. Telomere Shortening Occurs Early During Breast Tumorigenesis: A Cause of Chromosome Destabilization Underlying Malignant Transformation? , 2004, Journal of Mammary Gland Biology and Neoplasia.
[27] W. Murdoch,et al. Oxidative Damage to DNA of Ovarian Surface Epithelial Cells Affected by Ovulation: Carcinogenic Implication and Chemoprevention , 2004, Experimental biology and medicine.
[28] E. Montgomery,et al. Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis , 2004, Clinical Cancer Research.
[29] T. Cech. Beginning to Understand the End of the Chromosome , 2004, Cell.
[30] W. Gage,et al. Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. , 2002, The American journal of pathology.
[31] N. Inaba,et al. The relationship between telomere length and telomerase activity in gynecologic cancers. , 2002, Gynecologic oncology.
[32] T. von Zglinicki. Oxidative stress shortens telomeres. , 2002, Trends in biochemical sciences.
[33] P. V. van Diest,et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.
[34] Rochelle L. Garcia,et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. , 2001, Gynecologic oncology.
[35] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[36] R. Datar,et al. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas. , 1999, Gynecologic oncology.
[37] F. Jänicke,et al. Differential telomerase activity, expression of the telomerase catalytic sub‐unit and telomerase‐RNA in ovarian tumors , 1999, International journal of cancer.
[38] R. Jensen,et al. BRCA1 Expression Restores Radiation Resistance in BRCA1-defective Cancer Cells through Enhancement of Transcription-coupled DNA Repair* , 1999, The Journal of Biological Chemistry.
[39] M. Egholm,et al. Single base discrimination of CENP-B repeats on mouse and human Chromosomes with PNA-FISH , 1999, Mammalian Genome.
[40] T. Ide,et al. Telomerase activity in ovarian tumors , 1997, Cancer.
[41] C. Harley,et al. Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[43] S. D. Mearses. ENDOMETRIAL CARCINOMA. , 1963, The Medical journal of Malaya.